Browse by category

A brain-computer interface reveals the tirzepatide has a short-term or incomplete effect on related brain activity in a patient with obesity, calling for further study, a study by University of Pennsylvania School of Medicine has found. The nucleus accumbens on a brain CT of a patient (Credit: Penn Medicine) The research suggests that the medication, a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist, may be able to treat

A study from the Keck School of Medicine of USC found that sucralose, a common sugar substitute, alters brain activity related to hunger...